What We're Reading: Page 312
Industry reads hand-picked by our editors
Jan 13, 2017
Jan 12, 2017
-
The Washington Post
Trump on drug prices: Pharma companies are ‘getting away with murder’
-
TheStreet
Key insurer drops Mylan's EpiPen as Bresch reflects on tumultuous 2016 at JPM
-
NJ.com
At Christie's direction, N.J.'s AG moves to rein in opioid prescriptions
-
USA Today
CVS targets EpiPen with cheaper, generic version
Jan 11, 2017
-
CNBC
Mylan CEO Bresch said company has learned from EpiPen furor, hopes Trump appreciates 'decisive action' on pricing controversy
-
Forbes
Billionaire John Kapoor stepping down as CEO, chairman of opioid maker insys
-
The Baltimore Sun
Maryland lawmakers push to rein in drug prices
-
The Wall Street Journal
‘Take your medicine’ is big pharma’s best prescription
Jan 10, 2017
Jan 09, 2017
Jan 06, 2017
-
Bloomberg
Cheating death can cost $200,000 as cancer tops pharma sales
-
The Wall Street Journal
Teva gives downbeat earnings forecast
-
Forbes
Company will raise $1 billion to create blood test to detect cancer
-
Life Sci VC
Crystal ball gazing: biotech predictions for 2017
Jan 05, 2017
-
EP Vantage
Pharma stocks battered in 2016 storm
-
The Washington Post
Biden to tackle broad range of cancer issues, including drug prices, after leaving White House
-
The Wall Street Journal
Pennsylvania is ordered to provide hepatitis C drug to inmate
-
Boston Business Journal
Cambridge's Neon gets $70M infusion to develop 'bespoke cancer vaccine'
Previous
